Mary E. Luck is an accomplished inventor based in Fort Worth, TX (US). She has made significant contributions to the field of biocidal technology, particularly in the development of methods to enhance the safety and efficacy of cationic biocides in medical devices. Her innovative approach has the potential to improve patient outcomes in various medical applications.

Latest Patents

Mary E. Luck holds one patent titled "Interaction control of cationic biocides using labile anionic polyelectrolytes." This patent describes methods for inhibiting the uptake of cationic biocides into medical devices such as contact lenses and implants. Additionally, it outlines methods for stabilizing emulsions containing cationic biocides. The invention emphasizes the use of polymers that act as labile anionic polyelectrolytes to reversibly bind cationic biocides, thereby reducing their deleterious effects while maintaining biocidal activity. Preferred polymers mentioned in the patent include galactomannan and polyvinyl alcohol.

Career Highlights

Mary E. Luck is associated with Alcon Research, Ltd., where she has been instrumental in advancing research in biocidal applications. Her work focuses on enhancing the safety and effectiveness of medical devices through innovative chemical solutions.

Collaborations

Some of her notable coworkers include Howard Allen Ketelson and Ryan Desousa, who have collaborated with her on various projects related to biocidal technology.

Conclusion

Mary E. Luck's contributions to the field of biocidal technology demonstrate her commitment to improving medical device safety and efficacy. Her innovative methods and collaborative efforts continue to pave the way for advancements in this critical area of healthcare.

Profile summary based on public USPTO records.